Editas Medicine
EDIT
EDIT
234 hedge funds and large institutions have $263M invested in Editas Medicine in 2024 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 65 increasing their positions, 72 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14.47% less ownership
Funds ownership: 83.04% → 68.57% (-14%)
48% less capital invested
Capital invested by funds: $504M → $263M (-$240M)
Holders
234
Holding in Top 10
–
Calls
$2.6M
Puts
$1.83M
Top Buyers
| 1 | +$3.82M | |
| 2 | +$3.81M | |
| 3 | +$2.21M | |
| 4 |
HF
HRT Financial
New York
|
+$1.39M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$1.28M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$7.76M | |
| 3 | -$4.04M | |
| 4 |
Two Sigma Investments
New York
|
-$3.96M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$3.9M |